Literature DB >> 9419782

Amniotic fluid interleukin-6 and interleukin-8 levels predict the success of tocolysis in patients with preterm labor.

J R Allbert1, R W Naef, K G Perry, E F Magann, N S Whitworth, J C Morrison.   

Abstract

OBJECTIVE: To determine whether the levels of the cytokines interleukin-6 (IL-6) and IL-8 in amniotic fluid identify patients with preterm labor who are resistant to tocolysis.
METHODS: Amniocenteses were performed in 23 women with documented preterm labor at 20-32 weeks' gestational age who were treated subsequently with tocolytics. The concentrations of IL-6 and IL-8 in amniotic fluid were determined by double-antibody radioimmunoassay methods using recombinant human IL standards.
RESULTS: Of the 23 patients, five failed to respond to tocolysis (four delivered within 48 hours), and of the remaining 18, all delivered more than 9 days after tocolysis was initiated (mean 31 +/- 10 days; range 9-61). In women who had failed tocolysis, discriminatory concentrations of IL-6 and IL-8 were 20 and 15 ng/mL, respectively. Of the patients who had amniotic fluid concentrations higher than these thresholds, all failed tocolysis (100% positive predictive value) and delivered within 6 days. The patients with levels below these discriminatory concentrations had successful tocolysis, and 17 of 18 delivered more than 2 weeks after treatment (95% negative predictive value).
CONCLUSION: The success of tocolysis and thus delivery remote from an episode of preterm labor is associated with discriminatory amniotic fluid IL-6 and IL-8 levels of less than 20 and less than 15 ng/mL, respectively. If the immunologic response that causes the release of IL-6 and IL-8 has not occurred, the likelihood of successful tocolysis is extremely high. However, if both IL-6 and IL-8 are elevated, tocolysis is likely to fail and delivery may occur within 48 hours.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 9419782     DOI: 10.1177/107155769400100404

Source DB:  PubMed          Journal:  J Soc Gynecol Investig        ISSN: 1071-5576


  7 in total

1.  Evidence that antibiotic administration is effective in the treatment of a subset of patients with intra-amniotic infection/inflammation presenting with cervical insufficiency.

Authors:  Kyung Joon Oh; Roberto Romero; Jee Yoon Park; JoonHo Lee; Agustin Conde-Agudelo; Joon-Seok Hong; Bo Hyun Yoon
Journal:  Am J Obstet Gynecol       Date:  2019-03-28       Impact factor: 8.661

2.  Critical appraisal and clinical utility of atosiban in the management of preterm labor.

Authors:  Olaleye Sanu; Ronald F Lamont
Journal:  Ther Clin Risk Manag       Date:  2010-04-26       Impact factor: 2.423

3.  Evidence of perturbations of the cytokine network in preterm labor.

Authors:  Roberto Romero; Jean-Charles Grivel; Adi L Tarca; Piya Chaemsaithong; Zhonghui Xu; Wendy Fitzgerald; Sonia S Hassan; Tinnakorn Chaiworapongsa; Leonid Margolis
Journal:  Am J Obstet Gynecol       Date:  2015-07-29       Impact factor: 8.661

4.  Influence of maternal age, gestational age and fetal gender on expression of immune mediators in amniotic fluid.

Authors:  Tobias Weissenbacher; Rüdiger P Laubender; Steven S Witkin; Andrea Gingelmaier; Barbara Schiessl; Franziskus Kainer; Klaus Friese; Udo Jeschke; Darius Dian; Katrin Karl
Journal:  BMC Res Notes       Date:  2012-07-24

5.  Pathogenesis to treatment: preventing preterm birth mediated by infection.

Authors:  J A McGregor; J I French
Journal:  Infect Dis Obstet Gynecol       Date:  1997

6.  A rapid interleukin-6 bedside test for the identification of intra-amniotic inflammation in preterm labor with intact membranes.

Authors:  Piya Chaemsaithong; Roberto Romero; Steven J Korzeniewski; Alicia Martinez-Varea; Zhong Dong; Bo Hyun Yoon; Sonia S Hassan; Tinnakorn Chaiworapongsa; Lami Yeo
Journal:  J Matern Fetal Neonatal Med       Date:  2015-09-25

7.  Compartmentalized profiling of amniotic fluid cytokines in women with preterm labor.

Authors:  Gaurav Bhatti; Roberto Romero; Gregory Edward Rice; Wendy Fitzgerald; Percy Pacora; Nardhy Gomez-Lopez; Mahendra Kavdia; Adi L Tarca; Leonid Margolis
Journal:  PLoS One       Date:  2020-01-16       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.